# BME100 f2014:Group11 L2

Jump to: navigation, search
BME 100 Fall 2014 Home
People
Lab Write-Up 1 | Lab Write-Up 2 | Lab Write-Up 3
Lab Write-Up 4 | Lab Write-Up 5 | Lab Write-Up 6
Course Logistics For Instructors
Photos
Wiki Editing Help

# OUR TEAM

 Name: Aliya Yano Name: Breanna Corrigan Name: Julian Lopez Name: Carlos Cabanes Name: Mohammed Almaimani

# LAB 2 WRITE-UP

## Descriptive Statistics

Experiment 1

Rat Study

 LPS Dose Average Standard Deviation Standard Error 0mg 10.516 2.225551617 0.995296941 10mg 11.112 7.402885924 3.310671231

Experiment 2

Human Study

 LPS Dose Average Standard Deviation Standard Error 0mg 3.834 1.523010177 2.611737366 5mg 8.932 1.593931547 3.374809028 10mg 61.622 30.11069386 11.41919326 15mg 657.941 7.402885924 31.65975232

Experiment 1
Rat Study

Experiment 2
Human Study

## Analysis

Experiment 1
For the rat study, an unpaired t-test was conducted. This was the test of choice because there were only two groups of dosage levels and the subjects were all different.
This test produced a P-value of 0.867. This is larger than 0.05 and would suggest that there is no statistical difference.

Experiment 2
For the human studies experiment, an ANOVA test was chosen because there are more than two dosage levels being compared.
The test produced a P-value of 1.4X10^-16. This is significantly smaller than 0.05, therefore there is a statistical difference between the groups.
ANOVA Graph

## Summary/Discussion

The date gathered from the human study suggests that the LPS treatments did indeed increase Inflammotin levels in the elderly patients. Of course, the higher the dosage the greater the increase. This was proven correct by the ANOVA test, which found a P-value of 1.40X10^-16. This value is much lower than 0.05 and proves there to be a significant statistical difference between the groups. However, this was not the same in the test conducted on rats. The t-test for that experiment found a P-value of .867 which is greater than 0.05 and suggests that there was no statistically significant difference between the groups. Of course, we cannot always assume that treatments will affect rats and humans the same way. What works on a human may not work on a rat and vice versa. The LPS treatments increased Inflammotin levels in humans but it did not have any clear results in rats.